Analysis of mitochondrial DNA in discordant monozygotic twins with neurofibromatosis type 1. 2007

Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
Department of Neuropediatrics, Charité, University Medical Center, Berlin, Germany.

Neurofibromatosis type 1 (NF1) is the most frequent neurocutaneous disorder with autosomal dominant inheritance. Phenotype variability is high ranging from merely several café-au-lait spots to malignant peripheral nerve sheath tumors or severe disfigurement through plexiform neurofibromas. Identification of genetic factors that modify the NF1 phenotype would contribute to the understanding of NF1 pathophysiology and improve patient counselling. As even monozygotic (MZ) twins with NF1 may differ phenotypically, we wondered whether these variations might be inherited in a non-Mendelian fashion. Mitochondrial DNA (mtDNA) is inherited extrachromosomally through the cytoplasm of the oocyte and often harbours heteroplasmic sequence variations. At the time of blastomere separation, these variants may be skewedly distributed and effect phenotypic differences. Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation. MtDNA was extracted from nucleated blood cells of four pairs of discordant MZ twins with NF1 and from cutaneous neurofibromas of one twin pair. We sequenced the entire mitochondrial genome and determined the state of heteroplasmy by investigating a microsatellite region of the mitochondrial D-loop (D310-tract). The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene. Monozygosity was verified by genotyping. However, we did not detect evidence for mtDNA sequence differences or for different degrees of heteroplasmy between individuals of the same twin pair. The phenotypic discordance of MZ twins with NF1 cannot be explained by skewed distribution of mtDNA mutations or polymorphisms.

UI MeSH Term Description Entries
D008297 Male Males
D009456 Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS). Peripheral Neurofibromatosis,Recklinghausen Disease of Nerve,von Recklinghausen Disease,Cafe-au-Lait Spots with Pulmonic Stenosis,Molluscum Fibrosum,NF1 (Neurofibromatosis 1),Neurofibromatosis I,Neurofibromatosis Type 1,Neurofibromatosis Type I,Neurofibromatosis, Peripheral Type,Neurofibromatosis, Peripheral, NF 1,Neurofibromatosis, Peripheral, NF1,Neurofibromatosis, Type 1,Neurofibromatosis, Type I,Pulmonic Stenosis with Cafe-au-Lait Spots,Recklinghausen Disease, Nerve,Recklinghausen's Disease of Nerve,Recklinghausens Disease of Nerve,Watson Syndrome,von Recklinghausen's Disease,Cafe au Lait Spots with Pulmonic Stenosis,Neurofibromatoses, Peripheral,Neurofibromatoses, Type I,Neurofibromatosis, Peripheral,Peripheral Neurofibromatoses,Pulmonic Stenosis with Cafe au Lait Spots,Syndrome, Watson,Type 1 Neurofibromatosis,Type 1, Neurofibromatosis,Type I Neurofibromatoses,Type I, Neurofibromatosis,von Recklinghausens Disease
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004200 Diseases in Twins Disorders affecting TWINS, one or both, at any age. Diseases in Twin,Twin, Diseases in,Twins, Diseases in,in Twin, Diseases,in Twins, Diseases
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004272 DNA, Mitochondrial Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. Mitochondrial DNA,mtDNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes

Related Publications

Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
March 2010, American journal of medical genetics. Part A,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
June 1998, Annals of neurology,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
June 2011, Human mutation,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
October 2015, Sleep,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
May 1998, Clinical pediatrics,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
September 2023, Twin research and human genetics : the official journal of the International Society for Twin Studies,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
August 2016, Neurology(R) neuroimmunology & neuroinflammation,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
March 2017, American journal of medical genetics. Part A,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
January 1953, Archiv fur Kinderheilkunde,
Anne Katrin Detjen, and Sigrid Tinschert, and Dieter Kaufmann, and Bernd Algermissen, and Peter Nürnberg, and Markus Schuelke
January 1992, Acta geneticae medicae et gemellologiae,
Copied contents to your clipboard!